Jonathan Slonin

Jonathan Slonin

Chief Medical OfficeratPacira BioSciences· In proxies 2021–2024

Pay in FY2024+81% from the year before · Pacira BioSciences stock -44.2% the same year

Jonathan Slonin was paid $2.9M in FY2024 (Dec), up 81%. Pacira BioSciences stock fell 44.2% that year.

Pay$100 in the stock at the end of FY20 → $31
Pay is from the Summary Compensation Table of each Pacira BioSciences proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Pacira BioSciencesPublic company · 5 yr
    • Chief Medical Officer2021 – Present · 5 yrStock in role -39%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?